Quince Therapeutics Inc (QNCX)
0.95
+0.03
(+3.26%)
USD |
NASDAQ |
May 10, 16:00
0.9582
+0.01
(+0.86%)
Pre-Market: 20:00
Quince Therapeutics Total Assets (Quarterly): 167.90M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 167.90M |
September 30, 2023 | 85.39M |
June 30, 2023 | 88.84M |
March 31, 2023 | 93.32M |
December 31, 2022 | 103.91M |
September 30, 2022 | 109.78M |
June 30, 2022 | 117.86M |
March 31, 2022 | 116.13M |
December 31, 2021 | 133.23M |
September 30, 2021 | 147.42M |
June 30, 2021 | 161.39M |
Date | Value |
---|---|
March 31, 2021 | 174.52M |
December 31, 2020 | 189.47M |
September 30, 2020 | 204.66M |
June 30, 2020 | 219.21M |
March 31, 2020 | 231.20M |
December 31, 2019 | 124.37M |
September 30, 2019 | 133.41M |
June 30, 2019 | 143.24M |
March 31, 2019 | 70.60M |
December 31, 2018 | 72.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
85.39M
Minimum
Sep 2023
231.20M
Maximum
Mar 2020
144.49M
Average
133.41M
Median
Sep 2019
Total Assets (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 9.034M |
Palatin Technologies Inc | 13.55M |
iBio Inc | 34.02M |
Theriva Biologics Inc | 48.73M |
Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 82.82M |
Shareholders Equity (Quarterly) | 85.08M |